Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00872664 · ClinicalTrials.gov registry record · NA

Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented With Carotenoids

A NA study of Retinopathy of Prematurity, sponsored by University of Utah.

Completed
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT00872664: Completed NA study of Retinopathy of Prematurity, sponsored by University of Utah.

NCT00872664 is a NA study of Retinopathy of Prematurity that has completed, run by University of Utah. The registered enrollment target is 36 participants, below the 364-participant average among 7 other Retinopathy of Prematurity trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00872664, a NA study of Retinopathy of Prematurity, has completed, sponsored by University of Utah.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

The primary objectives of this study are to compare the serum and skin concentrations of beta-carotene, lutein, and lycopene in preterm infants fed preterm formulas with mixed carotenoids to serum concentrations in preterm infants fed preterm formulas with no added carotenoids and to human milk fed infants. The secondary objective of this study is to evaluate the effects of dietary carotenoids on the developing eye. Stages and zones of retinopathy of prematurity (ROP), retinal function, and retinal characteristics will also be examined.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT carotenoids

Study Locations (1)

Utah

  • University of Utah Health Sciences Center - Salt Lake City

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2009-09
Est. Completion 2013-06
Phase NA
University of Utah

818 total trials

What the finished NCT00872664 record still lists

NCT00872664 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 364-participant average among 7 other Retinopathy of Prematurity trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Retinopathy of Prematurity appearing as the primary indexed condition, and to 1 intervention - of which carotenoids is the first listed.

NCT00872664 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT00872664 about?

NCT00872664 is a clinical study titled "Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented With Carotenoids". The primary objectives of this study are to compare the serum and skin concentrations of beta-carotene, lutein, and lycopene in preterm infants fed preterm formulas with mixed carotenoids to serum concentrations in preterm infants fed preterm formulas with no added carotenoids and to human milk fed ...

What is the current status of trial NCT00872664?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2009-09. Estimated completion is 2013-06.

What conditions does trial NCT00872664 study?

This clinical trial studies the following conditions: Retinopathy of Prematurity.

What interventions are being tested in trial NCT00872664?

The interventions under investigation include: carotenoids (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00872664?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00872664 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Retinopathy of Prematurity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00872664, the US trial registry maintained by the National Library of Medicine. NCT00872664 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.